LTP001
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Novartis Pharmaceuticals
Overview
LTP001 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
LTP001 clinical trials
Explore related
Medical disclaimer. This page summarizes research about LTP001 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.